Elan Corporation

DUBLIN, Ireland--(BUSINESS WIRE)--March 31, 2006--Elan Corporation, plc today announced that it has filed with the Securities and Exchange Commission its Form 20-F for the fiscal year ended December 31, 2005 and has published its Annual Report for the fiscal year ended December 31, 2005. Both these documents are available on Elan's website at www.elan.com.

About Elan

Elan Corporation (NYSE: ELN), plc is a neuroscience-based biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.

CONTACT: Elan Corporation 
Investors:
Emer Reynolds, 353-1-709-4000
or
Chris Burns, 800-252-3526
or
Media:
Davia Temin, 212-407-5740
or
Elizabeth Headon, 353-1-498-0300 

SOURCE: Elan Corporation